BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 7955289)

  • 1. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
    Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
    Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of cardiac allograft vasculopathy: clinical insights from coronary angioscopy.
    Mehra MR; Ventura HO; Jain SP; Ramireddy K; Ali A; Stapleton DD; Smart FW; Ramee SR; Collins TJ; White CJ
    J Am Coll Cardiol; 1997 May; 29(6):1339-44. PubMed ID: 9137233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study.
    Mehra MR; Ventura HO; Chambers R; Collins TJ; Ramee SR; Kates MA; Smart FW; Stapleton DD
    J Am Coll Cardiol; 1995 Nov; 26(6):1537-44. PubMed ID: 7594082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor or recipient hepatitis B seropositivity is associated with allograft vasculopathy.
    Haji SA; Avery RK; Yamani MH; Tuzcu EM; Crowe TD; Cook DJ; Mawhorter SD; Hobbs R; Young JB; Smedira N; Starling RC
    J Heart Lung Transplant; 2006 Mar; 25(3):294-7. PubMed ID: 16507422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy.
    Mehra MR; Ventura HO; Stapleton DD; Smart FW; Collins TC; Ramee SR
    J Heart Lung Transplant; 1995; 14(4):632-9. PubMed ID: 7578168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes in heart transplant recipients.
    Li H; Tanaka K; Anzai H; Oeser B; Lai D; Kobashigawa JA; Tobis JM
    J Am Coll Cardiol; 2006 Jun; 47(12):2470-6. PubMed ID: 16781375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of donor gender on allograft vasculopathy: evidence from intravascular ultrasound.
    Erinc K; Yamani MH; Starling RC; Young JB; Crowe T; Ratliff NB; Cook DJ; Hobbs R; Bott-Silverman C; Rincon G; Smedira N; Tuzcu EM
    Transplant Proc; 2004 Dec; 36(10):3129-31. PubMed ID: 15686711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of preexistent donor coronary artery disease on the progression of transplant vasculopathy. An intravascular ultrasound study.
    Botas J; Pinto FJ; Chenzbraun A; Liang D; Schroeder JS; Oesterle SN; Alderman EL; Popp RL; Yeung AC
    Circulation; 1995 Sep; 92(5):1126-32. PubMed ID: 7648656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal.
    Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD
    J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allograft aortopathy: an in vivo study of donor aorta involvement in cardiac allograft vasculopathy.
    Mehra MR; Ventura HO; Stapleton DD; Karsan AK; Smart FW; Ramee SR; Collins TJ
    Am Heart J; 1997 Jun; 133(6):698-702. PubMed ID: 9200398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical coherence tomography and intravascular ultrasound evaluation of cardiac allograft vasculopathy with and without intimal neovascularization.
    Ichibori Y; Ohtani T; Nakatani D; Tachibana K; Yamaguchi O; Toda K; Akasaka T; Fukushima N; Sawa Y; Komuro I; Kotani J; Sakata Y
    Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):51-8. PubMed ID: 25976347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic activation of integrin alphaVbeta3 in donors with spontaneous intracerebral hemorrhage is associated with subsequent development of vasculopathy in the heart transplant recipient.
    Yamani MH; Cook DJ; Tuzcu EM; Paul P; Ratliff NB; Yu Y; Hobbs R; Rincon G; Bott-Silverman C; Smedira N; Young JB; Starling RC
    J Heart Lung Transplant; 2005 Aug; 24(8):1014-8. PubMed ID: 16102435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of mode of donor brain death on cardiac allograft vasculopathy: an intravascular ultrasound study.
    Mehra MR; Uber PA; Ventura HO; Scott RL; Park MH
    J Am Coll Cardiol; 2004 Mar; 43(5):806-10. PubMed ID: 14998621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors.
    Escobar A; Ventura HO; Stapleton DD; Mehra MR; Ramee SR; Collins TJ; Jain SP; Smart FW; White CJ
    Am J Cardiol; 1994 Nov; 74(10):1042-6. PubMed ID: 7977044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospective study of the frequency and extent of donor-transmitted coronary disease after heart transplantation by intravascular ultrasound].
    Klauss V; Henneke KH; Rieber J; Spes C; Meiser B; Siebert U; Angermann CE; Theisen K; Mudra H
    Dtsch Med Wochenschr; 1997 Oct; 122(41):1235-41; discussion 1241-3. PubMed ID: 9378052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrotic Plaque and Microvascular Dysfunction Predict Early Cardiac Allograft Vasculopathy Progression After Heart Transplantation: The Early Post Transplant Cardiac Allograft Vasculopathy Study.
    Chih S; Chong AY; Džavík V; So DY; Aleksova N; Wells GA; Bernick J; Overgaard CB; Stadnick E; Mielniczuk LM; Beanlands RSB; Ross HJ
    Circ Heart Fail; 2023 Jun; 16(6):e010173. PubMed ID: 37165901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients.
    Eisen HJ; Tuzcu EM; Dorent R; Kobashigawa J; Mancini D; Valantine-von Kaeppler HA; Starling RC; Sørensen K; Hummel M; Lind JM; Abeywickrama KH; Bernhardt P;
    N Engl J Med; 2003 Aug; 349(9):847-58. PubMed ID: 12944570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary ultrasound assessment of morphological and functional abnormalities associated with cardiac allograft vasculopathy.
    Heroux AL; Silverman P; Costanzo MR; O'Sullivan EJ; Johnson MR; Liao Y; McKiernan TL; Balhan JE; Leya FS; Mullen GM
    Circulation; 1994 Jan; 89(1):272-7. PubMed ID: 8281657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study.
    Jimenez J; Kapadia SR; Yamani MH; Platt L; Hobbs RE; Rincon G; Botts-Silverman C; Starling RC; Young JB; Nissen SE; Tuzcu M; Ratliff NB
    J Heart Lung Transplant; 2001 Apr; 20(4):393-8. PubMed ID: 11295576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Allograft vasculopathy in the early phase of orthotopic heart transplantation: angiography, intravascular ultrasound and functional in vivo findings].
    Kerber S; Rahmel A; Karbenn U; Heinemann-Vechtel O; Fechtrup C; Lamp B; Block M; Budde T; Hoffmeier A; Weyand M
    Z Kardiol; 1994 Mar; 83(3):215-24. PubMed ID: 8178545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.